Stephen Lee Moore, D.O., F.A.C.C., F.H.R.S.

***** ****** ****** *******

Avon Lake, Ohio 44012

Phone: 440-***-**** email: ac0kaf@r.postjobfree.com

Positions:

One Health Cardiology

Owensboro Regional Hospital

Pleasant Valley Center

1301 Pleasant Valley Road, Suite 202

Owensboro, Kentucky 42303

September 2015-September 2016

Cardiovascular Consultants of Cleveland, Inc.

36100 Euclid Avenue, Suite 300

Willoughby, Ohio 44094

June 2010 -July 2015

Chief, Division of Cardiology

Euclid Hospital (Regional Hospital of Cleveland Clinic Foundation)

Cleveland, Ohio

January 2012 -January 2015

Director, Congestive Heart Failure Clinic

Euclid Hospital (Regional Hospital of Cleveland Clinic)

Cleveland, Ohio

January 2012-August 2015

Naples Interventional Cardiac Electrophysiology

311 Tamiami Trail North, Suite 201

Naples, Florida 34102

January 2009 -March 2010

Director, Cardiac Electrophysiology & Pacing North Ohio

Heart Center, Inc.

125 East Broad Street, Suite 305

Elyria, Ohio 44035

July 1992 -December 2008

Professorships:

Ohio University College of Osteopathic Medicine

Athens, Ohio

Clinical Assistant Professor of Cardiology

Case Western Reserve University, School of Medicine

Cleveland, Ohio

Clinical Assistant Professor of Cardiology

Education:

Cleveland Clinic Foundation

Cleveland, Ohio

Fellowship, Interventional Electrophysiology and Pacing

1990 to 1992

Cleveland Clinic Foundation

Cleveland, Ohio

Fellowship, Cardiovascular Diseases

1987 to 1990

Mt Clemens General Hospital

Mt Clemens, Michigan

Residency, Internal Medicine

1984 to 1987

Mt Clemens General Hospital

Mt Clemens, Michigan

Internship

1983 to 1984

University of Health Sciences

College of Osteopathic Medicine

Kansas City, Missouri

Doctor of Osteopathy 1983

University of Mississippi

Oxford, Mississippi

Bachelor of Sciences 1979

Certifications:

Clinical Cardiac Electrophysiology Subspecialty Examination

1996, 2006

NASPEXAM, Examination of Specialty Competency Cardiac

Pacing 1991

Cardiovascular Diseases Subspecialty Examination 1991

Diplomat, American Osteopathic Board of Internal Medicine 1990

Internal Medicine Specialty Examination 1989

Diplomat, National Board of Medical Examiners 1984

Awards:

NASPE Mark C. Lidwell Traveling Fellowship

OLV Hospital and Cardiovascular Institute

Aalst, Belgium, Pedro Brugada, M.D.

Professional Affiliations:

Northeast Ohio Sudden Cardiac Arrest Association-

Medical Director 2008 to 2009

American College of Cardiology Fellow

Heart Rhythm Society Fellow

American Medical Association

American Osteopathic Association

American Heart Association

Ohio Osteopathic Association

Cleveland Academy of Osteopathic Medicine Executive Board Member

Ohio State Medical Association

Licensure:

Ohio Medical License

Florida Medical License

Kentucky Medical License

Publications:

Wilkoff B, Williamson B, Stern R, Moore SL, et al; Strategic Programming of Detection and Therapy Parameters in Implantable Defibrillators Reduces Shocks in Primary Prevention Patients: Results from the PREPARE Study accepted by JACC May 2008

Day J, Olshansky B, Moore SL, Brown S, Stolen K, and Lerew DR; High defibrillation Energy Requirements are Encountered Rarely with Modern Dual-chamber Implantable Cardioverter-Defibrillator Systems Europace, March 2008; 10:347-350

Moore SL, Stern R, Brown ML, Heubner BM, and Johnson J; Longer Ventricular Fibrillation Detection Duration Does Not Increase rate of Undersensing: Results from the PREPARE Study Circulation, Oct 2007; Volume 116, Part II

Olshansky B, Day J, Moore SL, et al; is Dual –Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?: Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing with AVSH in ICDs ) Study Circulation, January 2007; Volume 115

Moore SL, Edel T, Castle L, North Ohio Heart Center, Elyria, Ohio. Single center Experience: Safety and Efficacy of Defibrillators Implanted Under General Anesthesia vs. Conscious Sedation. (abstract) submitted to NASPE May 1998

Moore SL, Heisel A, Edel T, North Ohio Heart Center, Elyria, Ohio. Comparison of Sub-muscular and Subcutaneous Defibrillator Implant Techniques. (abstract) submitted to NASPE and CardioStim May 1998

Moore SL, Edel T, Higgins S, Pacifico A, Ellenbogen K, Wilber D, (VENTAK AV IIDR Acute Study Investigator Group), Alana Zbu M.S. (Guidant/CPI) A Randomized Controlled Clinical Trial Comparing VF Detection between the VENTAK AV IIDR and the VENTAK AV (abstract) submitted to NASPE and CardioStim May 1998

Moore SL, Wilkoff BL: Disturbances of Conduction. The High Risk Patient Management of Critically Ill. Leas & Fegiber, Philadelphia, PA, 1995

Moore SL, Firstenberg M, Trohman R, Sterba R, “long Term Effects of Radiofrequency Catheter Ablation on Previously Implanted Pacemakers”, (abstract) PACE ’93, May 1993

Moore SL, Firstenberg M, Sterba R, “Adenosine Testing to Differentiate Atrial Tachycardia Mechanisms”, (abstract) PACE’93, May 1993; Vol. 16, Part II. 1993

Moore SL, Firstenberg M, Trohman R, Sterba R, Maloney J, “Long Term Effects of Radiofrequency Catheter Ablation on Previously Implanted Pacemakers” (abstract) Journal of Pacing and Clinical Electrophysiology, April 1993; 14:947

Moore SL, Firstenberg M, et al: Effects of Radiofrequency Catheter Ablation on Permanent Pacemaker Function. Circulation Oct. 1992 Vol. 86, No. 4 I-44

Moore SL, Firstenberg M, Simmons T, Trohman R, “The Interaction Between Radiofrequency Ablation and Permanent Pacemakers”, (abstract) Circulation October 1992, Vol 86:449

Moore SL, Firstenberg M, et al: Value of electrophysiology testing for routine implantable defibrillator placement. EUR J.C.P.E. June 1992. Vol 2, No.2, A120.

Moore SL, Edel T, et al: Mortality predictors in patients with implantable cardioverter defibrillators. EUR J.C.P.E. June 1992. Vol 2, No.2, A124

Moore SL, Firstenberg M, Trohman R, et al: Should implantable caardioverter defibrillators be routinely replaced? PACE 1992; April Vol 15, Part II, 585

Moore SL, Maloney JD, et al: Automatic implantable cardioverter defibrillator implantation by non-thoracotomy approach: initial clinical experience with redesigned tranvenous lead system. PACE 1991; 14:623 (abstract)

Moore SL, Maloney JD, et al: Automatic implantable cardioverter defibrillator implantation by non-thoracotomy approach: Initial clinical experience with the redesigned transvenous lead system. Precedings of the IXth World Symposium on Cardiac Pacing and Electrophysiology. PACE 1991; Nov. Vol.14, No. 11 Part 11,1865-1869.

Moore SL, Maloney JD, et al: Defibrillator implant without thoracotomy mostly successful. Cardiology World News Nov/Dec 1991; 28.

Moore SL, Edel T, et al: Significance of first magnet charge time tests in Ventak implantable cardioverter defibrillators. JACC 1991; 17 (suppl A): 86A

Moore SL, Wilkoff BL: Rhythm disturbances after cardiac surgery. Seminars in Thoracic and Cardiovascular Surgery 1991; 3:24-28

Moore SL, Trohman R, ey al: Clinical experience with the second generation cardioverter defibrillator. PACE 1990; 13:1205 (abstract)

Moore SL, Firstenberg M, et al: Five-year clinical device life of implantable cardioverter defibrillators. PACE 1990; 13:1205 (abstract)

Moore SL, Edel T, Castle L, “Safety and Efficacy of Defibrillators Implanted Under Conscious Sedation in the Catheterization Laboratory” (abstract)

Day J, Olshansky B, Moore SL, et al: High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace 2008 10:347-350

Olshansky B, Day J, Moore SL, et al: Is Dual Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) Study. Circulation 115(1): 9-16 January 2007.

Helsel A, Moore SL, Meisel E, Kluge P, Germans L, Jung J, Fries R, Universities of Hamburg Dresden and Leipzig, Germany; North Ohio Heart Center, Elyria, Ohio; Thomas Hospital, Nashville, TN. Chronic Stability of Defibrillation Threshold: Comparison Between a Hot and a Cold Can ICD System.(abstract) NASPE and CardioStim May 1998

Wilkoff BL, Firstenberg M, Moore SL, Ching B, “Lead Impedance Velocity as a Predictor of Pacing Lead Instability” (abstract) Journal of Pacing and Clinical Electrophysiology, April 1993; 14:930

Trohman RG, Simmons TW, Moore SL, et al: Catheter ablation of the atrioventricular junction using radiofrequency energy and a bilateral cardiac approach. American Journal Cardiology Dec 1992.

Firstenberg M, Wilkoff BL, Pashkow F, Moore SL, et al: I.M.A.G.E. – A model for arrhythmia patient care: 21st century concepts available today. EUR J.C.P.E. June 1992. Vol 2 No 2, A56

Williams D, Arnold A, Edel T, Firstenberg M, Moore SL, et al: Long-term survival of women with implantable cardioverter defibrillators. EUR J.C.P.E. June 1992. Vol. 2 No. 2, A125

Sterba R, Moore SL, et al: Ablative therapy for fascicular tachycardia: technique and results. EUR J.C.P.E. June 1992. Vol. 2, No.2, A174

Sterba R, Trohman R, Moore SL, et al: Catheter ablation for a fascicular tachycardia; technique, results, follow-up. PACE 1992; April Vol.15, Part II 589

Firstenberg M, Moore SL, Ching RN, et al: Prognosis following treatment with a pacemaker and an implantable cardioverter defibrillator. PACE 1992; April Vol15, Part II 509

Rashidi R, Trohman R, Moore SL, et al: Importance of cutaneous patch location in radiofrequency catheter ablation. PACE 1992; April Vol.15, Part II 589

Edel T, Maloney JD, Moore SL, et al: Analysis of deaths in patients with an implantable cardioverter defibrillator: PACE 1992; Jan. Vol. 15, No. 1 60-70

Edel T, Maloney JD, Moore SL, et al: Six year clinical experience with the automatic implantable cardioverter defibrillator. PACE 1991; Nov. Vol.14, No 11 Part II, 1850-1854

Trohman RG, Moore SL, Sterba R: Wolff-Parkinson-White Syndrome: Risk stratification and management. CARDIO 1991; 8:40-56

Gohn D, Edel T, Moore SL, et al: High defibrillation thresholds: univarient and multivarient analysis. JACC 1991; 17 (suppl A): 86

Gohn D, Edel T, Moore SL, et al: Determinants of operative mortality in implantable cardioverter defibrillators. JACC 1991; 17 (suppl A): 86A

McGuinn WP, Wilkoff BL, Moore SL, et al: Treatment of automatically mediated syncope with rapid AV sequential pacing on demand. JACC 1991; 17 (suppl A): 271A

Edel T, Moore SL, et al: Six year clinical experience with the automatic implantable cardioverter defibrillator. PACE 1991; 14:642 (abstract)

McGuinn WP, Moore SL, et al: Temporary dual-chamber pacing during tilt-table testing for vasovagal syncope: A predictor of therapeutic success. PACE 1991; 14:734 (abstract)

Firstenberg M, Edel T, McAllister H, Moore SL, et al: Clinical predictors of poor prognosis in patients with implantable cardioverter defibrillators. PACE 1990; 13:1195 (abstract)

Firstenberg M, Moore SL, et al: Long-term follow-up of implantable cardioverter defibrillators PACE 1990; 13:1195 (abstract)

“Are We Overestimating Percentage of Right Ventricular Pacing in Patients with Implantable Cardioverter Defibrillators?” HFSA 2006 10th Annual Scientific Meeting, July 2006 (abstract)

Biventricular pacing improves myocardial performance through either simultaneous or V-V optimized modes: a sub-study of the Rhythm ICD Multicenter Trial (abstract)

Presentations:

Available upon request

Research:

Available upon request

Physician Signature Date

Stephen L. Moore, D.O., F.A.C.C., F.H.R.S.

Contact this candidate